Daniel M. Canafax

THE IMPACT OF CYCLOSPORINE AND COMBINATION IMMUNOSUPPRESSION ON THE INCIDENCE OF POSTTRANSPLANT DIABETES IN RENAL ALLOGRAFT RECIPIENTS

J. Philip Boudreaux, Lois McHugh, Daniel M. Canafax et al. · Transplantation · 1987 · 220 citations

Medicine, Immunology, Nephrology +11

A Single Institution, Randomized, Prospective Trial of Cyclosporine Versus Azathioprine-Antilymphocyte Globulin for Immunosuppression in Renal Allograft Recipients

John S. Najarian, David S. Fryd, M Strand et al. · Annals of Surgery · 1985 · 163 citations · Full text

Medicine, Nephrology, Pharmacology +11

Clinical Pharmacokinetics of XP13512, a Novel Transported Prodrug of Gabapentin

Kenneth C. Cundy, Srikonda V. Sastry, Wendy Luo et al. · The Journal of Clinical Pharmacology · 2008 · 125 citations

Pharmacy, Clinical Pharmacokinetics, Pharmacology +14

Azathioprine Metabolism: Pharmacokinetics of 6‐Mercaptopurine, 6‐Thiouric Acid and 6‐Thioguanine Nucleotides in Renal Transplant Patients

Gary L. C. Chan, Gary R. Erdmann, Scott A. Gruber et al. · The Journal of Clinical Pharmacology · 1990 · 124 citations

Medicine, Pharmacokinetics, Pharmacology +16

INTERACTION BETWEEN CYCLOSPORINE AND FLUCONAZOLE IN RENAL ALLOGRAFT RECIPIENTS

Daniel M. Canafax, Nina M. Graves, Donald M. Hilligoss et al. · Transplantation · 1991 · 107 citations

Medicine, Pharmacokinetics, Pharmacology +16